Immunogenic polypeptide cocktail for the treatment of medullary thyroid carcinoma
US9872894B2 · kind B2 · utility
1Cited by
1References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 17, 2017 |
| Grant date | Jan 23, 2018 |
| Priority date | — |
| Expiry date | Feb 17, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/70
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are immunogenic compositions that include one or more polypeptides that, when administered to a subject with adjuvant, elicit an immune response against medullary thyroid cancer. Disclosed are methods of eliciting an immune response and/or treating cancer, such as medullary thyroid carcinoma or other thyroid carcinomas.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.